Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Agent Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
BOSTON--(BUSINESS WIRE)--Jun 21, 2022--
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
ImCheck Therapeutics aims to broaden the reach of cancer immunotherapy with antibody drugs that activate a rare but powerful type of immune cell called gamma delta T cells. The biotech has unveiled €96 million to advance its pipeline, including a lead candidate in development for both liquid and solid tumors.